{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:22:42Z","timestamp":1767183762189,"version":"3.41.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The aim of the study was to describe trends in cervical cancer screening and outcomes for women under 25 years of age in Belgium between 2010 and 2019 in response to a changed reimbursement policy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>We used the databases of the National Health Insurance Institute (RIZIV\/INAMI) and the Belgian Cancer Registry (BCR) for a nationwide description of cervical screening, subsequent diagnostic procedures and outcomes for women younger than 20 years and women aged 20\u201325 years between 2010 and 2019.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Over a 10-year period, the number of cytology screening tests and annual screening rates in women younger than 25 years have been reduced by 50%, but no increases in invasive cervical cancer or high-grade intraepithelial lesion diagnoses were observed. The major determinant of this decreased overscreening has been the limitation of reimbursement in 2013 to once every 3 years instead of once every 2 years. In women aged 25\u201329 years, there is no increase in invasive cervical cancer diagnoses after decreased screening of women younger than 25 years. To detect 29 invasive cervical cancers in women younger than 25 during the 10-year study period, a total of 5606 conizations were performed and 43 million EUR of Belgian health insurance budget was spent. Since the cost of hospitalization, sickness leave and negative psychological impact were not included in our estimation, these costs are underestimated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Incidence of cervical cancer in women under 25 years remains low and screening is not effective in preventing cervical cancer, although there is clear evidence of potential reproductive harm and financial cost. We state that restricting reimbursement of cervical cancer screening before the age of 25 will improve guideline adherence and decrease healthcare expenditures without negatively impacting the health of the population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cej.0000000000000770","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T10:00:09Z","timestamp":1663840809000},"page":"163-170","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Cervical cancer screening and outcomes for women under 25 years of age in Belgium: a 10-year nationwide study"],"prefix":"10.1097","volume":"32","author":[{"given":"Fabian","family":"Desimpel","sequence":"first","affiliation":[{"name":"University Hospital of Brussels, Free University of Brussels, Brussels"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Declercq","sequence":"additional","affiliation":[{"name":"ZNA Middelheim Hospital, Antwerp"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Makar","sequence":"additional","affiliation":[{"name":"ZNA Middelheim Hospital, Antwerp"},{"name":"Department of Gynaecology, University Hospital Ghent, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,9,12]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.ejca.2009.07.018","article-title":"Trends of cervical cancer mortality in the member states of the European Union.","volume":"45","author":"Arbyn","year":"2009","journal-title":"Eur J Cancer"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/ijc.26248","article-title":"Frequency of cervical intraepithelial neoplasia treatment in a well-screened population.","volume":"130","author":"Barken","year":"2012","journal-title":"Int J Cancer"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1038\/s41598-018-24882-2","article-title":"Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis.","volume":"8","author":"Bekos","year":"2018","journal-title":"Sci Rep"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ijc.30152","article-title":"Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?","volume":"139","author":"Castanon","year":"2016","journal-title":"Int J Cancer"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1503\/cmaj.113-2136","article-title":"Recommendations on screening for cervical cancer.","volume":"185","author":"Dickinson","year":"2013","journal-title":"CMAJ"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/ijc.30524","article-title":"Harms of cervical cancer screening in the United States and the Netherlands.","volume":"140","author":"Habbema","year":"2017","journal-title":"Int J Cancer"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/CEJ.0000000000000701","article-title":"Updated evidence-based recommendations for cervical cancer screening in France.","volume":"31","author":"Hamers","year":"2022","journal-title":"Eur J Cancer Prev"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ypmed.2019.04.010","article-title":"Trends in cervical cancer incidence rates by age, race\/ethnicity, histological subtype, and stage at diagnosis in the United States.","volume":"123","author":"Islami","year":"2019","journal-title":"Prev Med"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/jnci\/djab080","article-title":"Real-World effectiveness of human papillomavirus vaccination against cervical cancer.","volume":"113","author":"Kjaer","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2147\/CMAR.S195098","article-title":"Cervical cancer in women aged 25 years or younger: a retrospective study.","volume":"11","author":"Kong","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"i3633","DOI":"10.1136\/bmj.i3633","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis.","volume":"354","author":"Kyrgiou","year":"2016","journal-title":"BMJ"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/bjc.2014.65","article-title":"Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years.","volume":"110","author":"Landy","year":"2014","journal-title":"Br J Cancer"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/LGT.0000000000000215","article-title":"Regression and progression predictors of CIN2 in women younger than 25 years.","volume":"20","author":"Loopik","year":"2016","journal-title":"J Low Genit Tract Dis"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ygyno.2017.09.010","article-title":"Impact of organized and opportunistic Pap testing on the risk of cervical cancer in young women - A case-control study from Finland.","volume":"147","author":"Makkonen","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R20a-20250527","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/CEJ.0000000000000360","article-title":"Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.","volume":"27","author":"Maura","year":"2018","journal-title":"Eur J of Canc Prev"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/ajo.12640","article-title":"Cervical cancer in women under 25 years of age in Queensland, Australia: to what extent is the diagnosis made by screening cytology?","volume":"57","author":"Morgan","year":"2017","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/AOG.0b013e3181fe777f","article-title":"Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women.","volume":"116","author":"Moscicki","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/jayao.2015.0066","article-title":"Embryonal Rhabdomyosarcoma of the Cervix in Young Women.","volume":"5","author":"Narin","year":"2016","journal-title":"J Adolesc Young Adult Oncol"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"1700737","DOI":"10.2807\/1560-7917.ES.2018.23.41.1700737","article-title":"The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?","volume":"23","author":"Patel","year":"2018","journal-title":"Euro Surveill"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"e026292","DOI":"10.1136\/bmjopen-2018-026292","article-title":"Impact of screening on cervical cancer incidence in England: a time trend analysis.","volume":"9","author":"Pesola","year":"2019","journal-title":"BMJ Open"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/0969141315580836","article-title":"Exploring the trend of increased cervical intraepithelial neoplasia detection rates in the Netherlands.","volume":"22","author":"Rozemeijer","year":"2015","journal-title":"J Med Screen"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.bjc.6600974","article-title":"Benefit of cervical screening at different ages: evidence from the UK audit of screening histories.","volume":"89","author":"Sasieni","year":"2003","journal-title":"Br J Cancer"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"b2968","DOI":"10.1136\/bmj.b2968","article-title":"Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data.","volume":"339","author":"Sasieni","year":"2009","journal-title":"BMJ"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/LGT.0000000000000574","article-title":"Cervical screening practices and outcomes for young women in response to changed guidelines in Calgary, Canada, 2007-2016.","volume":"25","author":"Sayed","year":"2021","journal-title":"J Low Genit Tract Dis"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection.","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"359","DOI":"10.5694\/mja16.00289","article-title":"Impact of the Australian National Cervical Screening Program in women of different ages.","volume":"205","author":"Smith","year":"2016","journal-title":"Med J Aust"},{"key":"R32-20250527","first-page":"101","article-title":"HPV vaccination coverage in the federal state of Belgium according to regions and their impact.","volume":"10","author":"Tjalma","year":"2018","journal-title":"Facts Views Vis Obgyn"},{"key":"R33-20250527","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1158\/0008-5472.CAN-10-0621","article-title":"Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity.","volume":"70","author":"Trottier","year":"2010","journal-title":"Cancer Res"},{"key":"R34-20250527","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/CEJ.0000000000000155","article-title":"Cervical cancer screening in Belgium and overscreening of adolescents.","volume":"25","author":"Van Kerrebroeck","year":"2016","journal-title":"Eur J Cancer Prev"},{"key":"R36-20250527","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/cncr.23756","article-title":"Burden of cervical cancer in the United States, 1998-2003.","volume":"113","author":"Watson","year":"2008","journal-title":"Cancer"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:01:36Z","timestamp":1748361696000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,12]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000770","relation":{},"ISSN":["0959-8278"],"issn-type":[{"type":"print","value":"0959-8278"}],"subject":[],"published":{"date-parts":[[2022,9,12]]}}}